EXPERIMENTALLY DESIGNED, VALIDATED HPLC SIMULTANEOUS DETERMINATION OF PRIDINOL AND DICLOFENAC IN THEIR COMBINED PHARMACEUTICAL FORMULATIONS, WHICH ALLOWS LIMITING DICLOFENAC RELATED COMPOUND A

Author: Vignaduzzo Silvana   Castellano Patricia   Kaufman Teodoro  

Publisher: Taylor & Francis Ltd

ISSN: 1082-6076

Source: Journal of Liquid Chromatography & Related Technologies, Vol.33, Iss.19, 2010-01, pp. : 1720-1732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The development and validation of an HPLC method for the determination of pridinol and diclofenac in their combined formulations and the simultaneous limit testing of diclofenac related compound A is described. The separation was performed on a C18 column. Experimental design and response surface strategies were employed for optimizing detection wavelength (225 nm) and mobile phase composition [MeOH:2-propanol:phosphate buffer (50 mM, pH 5.5), 48:9:43 (v/v/v), 1 mL min-1], and for validation purposes. The method was successfully applied to the quality control of commercial brands of tablets and capsules. Found impurity levels were below 0.1% (LOQ = 0.02%). Stressed samples were also evaluated.

Related content